Skip to main content
Robert Orenstein, DO, Infectious Disease, Phoenix, AZ, Mayo Clinic Hospital

RobertOrensteinDOFIDSA, FACP, AAHIVS

Infectious Disease Phoenix, AZ

HIV/AIDS Medicine, Healthcare Associated Infections, Transplant/Immunocompromised States

Mayo Clinic in Arizona Infectious Diseases Division

Dr. Orenstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Orenstein's full profile

Already have an account?

Summary

  • I am a board certified Infectious Diseases specialist with expertise in the prevention and management of complex infections in the community, healthcare setting, traveler and immunocompromised host. My research focuses on prevention and management of healthcare acquired infections.

Education & Training

  • Virginia Commonwealth Univ
    Virginia Commonwealth Univ1991 - 1993
  • Geisinger Health System (Danville)
    Geisinger Health System (Danville)Residency, Internal Medicine, 1988 - 1991
  • Botsford General Hospital
    Botsford General HospitalInternship, Rotating Osteopathic Internship, 1987 - 1988
  • Des Moines University College of Osteopathic Medicine
    Des Moines University College of Osteopathic MedicineClass of 1987, D.O., Sigma Sigma Phi
  • Trinity College
    Trinity CollegeBS, Biochemistry , 1977 - 1981

Certifications & Licensure

  • AZ State Medical License
    AZ State License 2010 - 2023
  • MN State Medical License
    MN State License 2002 - 2023
  • VA State Medical License
    VA State License 1991 - 2008
  • PA State Medical License
    PA State License 1989 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease
  • American Academy of HIV MedicineHIV

Awards, Honors, & Recognition

  • Outstanding Quality improvement Team CAUTI prevention Mayo Clinic School of Continuing Professional Education, 2014
  • Fellow Infectious Diseases Society of America, 2008
  • Mayo Clinic Practice Innovation Award (CPI-10) 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Patient and Environmental Service Employee Satisfaction of Using Germicidal Bleach Wipes.  
    Aronhalt K, McManus J, Orenstein R, Faller R, Link M, Journal of Healthcare Quality 2012
  • West Nile Infection 2003.  
    Orenstein, R, Mayo Clinic Department of Internal Medicine Newsletter
  • TNF-Inhibitors and Infection.  
    Orenstein R, Matteson EL, Infect Med 2006; 23:99-114
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The management of severe falciparum malaria.
    Orenstein R, and Smith JL, Scientific meeting of PA,WVA American College of Physicians, Hershey, PA
  • Polymicrobial septic diskitis.
    Orenstein R, Scientific meeting of PA, WVA American College of Physicians, Pittsburgh, PA
  • Efficacy and Cost Effectiveness of Protective Devices to Reduce Needlestick Injuries in Healthcare Workers.
    Orenstein R, Karabaic M, Reynolds L, Redmond AL, Wong ES, 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA
  • Join now to see all

Lectures

  • The Benefits and Limitations of Needleless Devices and Needle Protector Systems. 
    The National Intravenous Nurses Association Annual Meeting, Phoenix, Arizona
  • Antibiotic Resistance. 
    Charlotte Postgraduate Fall Seminar, American Academy of Family Physicians, Charlotte, NA
  • Risk factors for urinary lithotripsy associated septicemia. 
    31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL
  • Join now to see all

Press Mentions

  • “All About the Mission”
    “All About the Mission”August 2nd, 2022
  • Inside a New COVID-19 Treatment That's Keeping Arizonans Out of the Hospital
    Inside a New COVID-19 Treatment That's Keeping Arizonans Out of the HospitalJanuary 30th, 2021
  • Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at ACG 2022
    Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at ACG 2022October 12th, 2022

Professional Memberships

Hospital Affiliations